New insider activity at Healthequity ( (HQY) ) has taken place on December 16, 2025.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Director Gayle Furgurson Wellborn recently sold 4,339 shares of Healthequity stock, amounting to a transaction value of $425,308.
Recent Updates on HQY stock
In the last 24 hours, HealthEquity’s stock has seen positive developments following its strong Q3 earnings report, which showcased a 7% revenue increase and significant growth in net income and adjusted EBITDA. Analysts have raised their price targets for HealthEquity, citing multiple growth options and the company’s strategic investments in technology and market expansion. Deutsche Bank increased its price target due to the company’s strong performance and growth prospects, while JPMorgan highlighted the role of artificial intelligence in improving margins. Citizens JMP also raised its price target, emphasizing HealthEquity’s positioning to benefit from HSA market expansion and favorable member rate mix. Despite macroeconomic uncertainties and potential pricing pressures, HealthEquity’s strategic initiatives and positive legislative environment are expected to support its continued growth trajectory.
Spark’s Take on HQY Stock
According to Spark, TipRanks’ AI Analyst, HQY is a Outperform.
HealthEquity’s strong financial performance and positive earnings call are the primary drivers of its stock score. The company’s robust growth metrics and strategic initiatives position it well for future success. However, the high P/E ratio suggests overvaluation, and technical indicators show neutral momentum, which tempers the overall score.
To see Spark’s full report on HQY stock, click here.
More about Healthequity
YTD Price Performance: -1.09%
Average Trading Volume: 882,731
Technical Sentiment Signal: Buy
Current Market Cap: $8.27B